FDA Adverse Event Other Summary report: N

RADIESSE VOICE

MDR report key: 2126502 · Received June 10, 2011

Report

Report Number
2135225-2011-00053
Event Type
Other
Date Received
June 10, 2011
Report Date
May 24, 2011
Manufacturer
MERZ AESTHETICS (FORMERLY BIOFORM MEDICAL)
Product Code
KHJ
PMA / PMN Number
K013243
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

NO PT IDENTIFIERS WERE PROVIDED. THE VOCAL FOLD AUGMENTATION WAS PERFORMED BY DR. (B)(6). THE AMOUNT OF RADIESSE VOICE INJECTED, THE INJECTION DATE, THE DATE OF SURGICAL REMOVAL AND THE RADIESSE VOICE LOT USED HAD NOT BEEN PROVIDED IN THIS ARTICLE. THEREFORE, THE DEVICE HISTORY RECORDS COULD NOT BE REVIEWED. THE PT OUTCOME AFTER THE CAHA WAS REMOVED, WAS NOT PROVIDED IN THE ARTICLE. THE AUTHOR (PHYSICIAN INJECTOR) INDICATES THAT THE PT'S SUPERFICIAL INJECTION WAS TECHNICAL IN NATURE AND NOT A SPECIFIC COMPLICATION OF RADIESSE VOICE.

Description of Event or Problem · 1

THIS ADVERSE EVENT WAS REPORTED IN THE JOURNAL: LONG-TERM RESULTS OF CAHA FOR VOCAL FOLD AUGMENTATION, THE LARYNGOSCOPE 121: 313-319, (B)(6) 2011. NINETY PTS (ALL OVER THE AGE OF (B)(6)) WHO HAD BEEN TREATED WITH A TOTAL OF 108 VOCAL FOLD INJECTIONS WITH RADIESSE VOICE INJECTIONS WERE EVALUATED. THREE PTS EXPERIENCED ADVERSE EVENTS, REQUIRING SURGICAL REMOVAL OF THE CAHA. THE PT WAS INJECTED WITH RADIESSE VOICE (DATE NOT SPECIFIED); DURING THE INJECTION IT WAS NOTED THAT THE CAHA WAS SUPERFICIAL. ALTHOUGH THIS WAS NOT LIFE-THREATENING, THE SUPERFICIAL INJECTION DID REQUIRE SURGICAL REMOVAL. THE AUTHOR ALSO POINTS OUT THAT THIS COMPLICATION WAS TECHNICAL IN NATURE AND WAS NOT A CAHA-SPECIFIC COMPLICATION. THE SUPERFICIAL INJECTION OF CAHA IN THIS CASE, CAUSED SIGNIFICANT VIBRATORY STIFFNESS AND RESULTANT DYSPHONIA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RADIESSE VOICE INJECTABLE IMPLANT KHJ MERZ AESTHETICS (FORMERLY BIOFORM MEDICAL) UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention